Sam-A Pharm. Co. Ltd (009300) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.001x

Based on the latest financial reports, Sam-A Pharm. Co. Ltd (009300) has a cash flow conversion efficiency ratio of 0.001x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩162.42 Million ≈ $110.07K USD) by net assets (₩228.11 Billion ≈ $154.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 009300 market cap overview for the company's overall valuation and market capitalisation.

Sam-A Pharm. Co. Ltd - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how Sam-A Pharm. Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Sam-A Pharm. Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sam-A Pharm. Co. Ltd ranked by their cash flow conversion efficiency. Explore 009300 cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Arlitech Electronic TWO:6432	0.043x
Kuk Dong KO:005320	-0.103x
Apollo Minerals Ltd AU:AON	-0.137x
FORTE MINERALS CORP. F:2OA	-0.055x
Ma Kuang Healthcare Holding Ltd TWO:4139	0.097x
MacroWell OMG Digital Entertainment Co Ltd TWO:3687	0.021x
INmune Bio Inc NASDAQ:INMB	-0.323x
Chilwa Minerals Ltd AU:CHW	-0.071x

Annual Cash Flow Conversion Efficiency for Sam-A Pharm. Co. Ltd (2009–2025)

The table below shows the annual cash flow conversion efficiency of Sam-A Pharm. Co. Ltd from 2009 to 2025. View Sam-A Pharm. Co. Ltd (009300) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩228.11 Billion ≈ $154.59 Million	₩10.72 Billion ≈ $7.27 Million	0.047x	-59.04%
2024-12-31	₩219.98 Billion ≈ $149.07 Million	₩25.25 Billion ≈ $17.11 Million	0.115x	+10.83%
2023-12-31	₩200.47 Billion ≈ $135.86 Million	₩20.76 Billion ≈ $14.07 Million	0.104x	-4.59%
2022-12-31	₩180.62 Billion ≈ $122.40 Million	₩19.60 Billion ≈ $13.29 Million	0.109x	+44.26%
2021-12-31	₩172.02 Billion ≈ $116.58 Million	₩12.94 Billion ≈ $8.77 Million	0.075x	+32.98%
2020-12-31	₩166.29 Billion ≈ $112.69 Million	₩9.41 Billion ≈ $6.38 Million	0.057x	-28.04%
2019-12-31	₩168.15 Billion ≈ $113.95 Million	₩13.22 Billion ≈ $8.96 Million	0.079x	-0.82%
2018-12-31	₩160.90 Billion ≈ $109.04 Million	₩12.76 Billion ≈ $8.64 Million	0.079x	+142.87%
2017-12-31	₩156.10 Billion ≈ $105.79 Million	₩5.10 Billion ≈ $3.45 Million	0.033x	-53.85%
2016-12-31	₩148.92 Billion ≈ $100.92 Million	₩10.53 Billion ≈ $7.14 Million	0.071x	-8.33%
2015-12-31	₩140.08 Billion ≈ $94.93 Million	₩10.81 Billion ≈ $7.32 Million	0.077x	-9.06%
2014-12-31	₩134.15 Billion ≈ $90.91 Million	₩11.38 Billion ≈ $7.71 Million	0.085x	-26.49%
2012-12-31	₩121.33 Billion ≈ $82.22 Million	₩14.00 Billion ≈ $9.49 Million	0.115x	+21.89%
2011-12-31	₩110.58 Billion ≈ $74.94 Million	₩10.47 Billion ≈ $7.10 Million	0.095x	+89.49%
2010-12-31	₩101.99 Billion ≈ $69.12 Million	₩5.10 Billion ≈ $3.45 Million	0.050x	+147.91%
2009-12-31	₩79.92 Billion ≈ $54.16 Million	₩-8.33 Billion ≈ $-5.65 Million	-0.104x	--

About Sam-A Pharm. Co. Ltd

KQ:009300 Korea Pharmaceuticals

Market Cap

$57.91 Million

₩85.45 Billion KRW

Market Cap Rank

#21450 Global

#1253 in Korea

Share Price

₩14000.00

Change (1 day)

+0.07%

52-Week Range

₩12130.00 - ₩17290.00

All Time High

₩36150.00